Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Novartis has successfully launched a notes issue of EUR 1.5 billion with a coupon of 4.25% under its EUR 15 billion Euro Medium Term Note Programme. Proceeds will be used for general corporate purposes. The seven-year note was priced at 99.757% and has a maturity date of June 2016. It is guaranteed by Novartis AG, which is incorporated in Switzerland and is the ultimate parent company of Novartis Finance S.A., Luxembourg, the issuing entity.


   

Today in Medical Devices/Products...keeping you current

Medical Devices: How Do You Know They Are Safe
AMN Healthcare, 10/12/09

Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address